Physician profile
Brian G Moore
NPI 1205942075
$406.66
in general payments reported to CMS, 2019-2025
13 companies · $58.83 in 2025
The $58.83 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $35.31 · 2022: $151 · 2023: $136 · 2024: $25.97 · 2025: $58.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $220.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $100.81 | 2022-2025 | |
| Boston Scientific Corporation | $72.73 | 2023 | Watchman Access System |
| Sanara Medtech INC. | $35.31 | 2021 | |
| Smith+Nephew, INC. | $29.43 | 2022 | |
| Sanofi-Aventis U.S. LLC | $25.97 | 2024 | |
| Lilly USA, LLC | $22.89 | 2025 | Mounjaro, Zepbound |
| Janssen Pharmaceuticals, INC | $21.33 | 2022 | |
| Abbvie INC. | $20.95 | 2022 | |
| Pfizer INC. | $19.85 | 2023 | |
| Exact Sciences Corporation | $16.95 | 2025 | Cologuard Collection Kit |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.45 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.30 | 2023 | Jardiance |
| Paratek Pharmaceuticals, INC. | $11.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.